<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="emergence of coronavirus disease 2019 (COVID-19), which is caused by" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2), has caused a large-scale global outbreak"/>
 <result pre="rates in COVID-19 patients are associated with underlying comorbidities, including" exact="cardiovascular disease," post="diabetes, hypertension, and chronic obstructive pulmonary disease [10]. Remarkably,"/>
 <result pre="associated with underlying comorbidities, including cardiovascular disease, diabetes, hypertension, and" exact="chronic obstructive pulmonary disease" post="[10]. Remarkably, there is a bidirectional relationship between COVID-19"/>
 <result pre="proposed that SARS-CoV may damage islets and cause acute insulin-dependent" exact="diabetes mellitus" post="[16]. Whether there is a link between the development"/>
 <result pre="[25]. In a human challenge trials (HCTs) of an oral" exact="influenza" post="vaccine using adenovirus as a carrier, the levels of"/>
 <result pre="levels of binding antibody and neutralizing antibody of the adenovirus-vectored" exact="influenza" post="vaccine were lower than those of an inactivated vaccine,"/>
 <result pre="while the T-cell response and IgA level of the adenovirus-vectored" exact="influenza" post="vaccine were remarkably higher than those of the inactivated"/>
 <result pre="of the inactivated vaccine. The protection rate of the adenovirus-vectored" exact="influenza" post="vaccine was found to be significantly higher than that"/>
 <result pre="the cellular immune and IgA responses generated by an adenovirus-vectored" exact="influenza" post="vaccine play important roles in preventing influenza virus infection"/>
 <result pre="by an adenovirus-vectored influenza vaccine play important roles in preventing" exact="influenza" post="virus infection [26]. These findings suggest that a vaccine’s"/>
 <result pre="protection against respiratory viral diseases in most cases, such as" exact="influenza" post="and respiratory syncytial virus [27], [28]. The delivery route"/>
 <result pre="induction of local mucosal immunity. Studies on a live attenuated" exact="influenza" post="vaccine found that intranasal delivery of vaccination was more"/>
 <result pre="to enhance the immune responses of the elderly; examples include" exact="hepatitis" post="B vaccines and influenza vaccines [34], [35]. An ideal"/>
 <result pre="responses of the elderly; examples include hepatitis B vaccines and" exact="influenza" post="vaccines [34], [35]. An ideal candidate COVID-19 vaccine should"/>
 <result pre="challenged (whether or not they have been vaccinated) with an" exact="infectious disease" post="organism, such as SARS-CoV-2. The use of controlled HCTs—instead"/>
 <result pre="neutralizing antibody titersNat Med266202093294032393800 23YangZ.-y.WernerH.C.KongW.-p.LeungK.TraggiaiE.LanzavecchiaA.NabelG.J.Evasion of antibody neutralization in emerging" exact="severe acute respiratory syndrome" post="coronavirusesProceedings of the National Academy of Sciences10232005797801 24JinH.XiaoC.ChenZ.e.KangY.MaY.ZhuK.XieQ.TuY.YuY.WangB.Induction of"/>
 <result pre="11 years post-infectionVaccine341720162008201426954467 26LiebowitzD.GottliebK.KolhatkarN.S.GargS.J.AsherJ.M.NazarenoJ.KimK.McIlwainD.R.TuckerS.N.Efficacy, immunogenicity, and safety of an oral" exact="influenza" post="vaccine: a placebo-controlled and active-controlled phase 2 human challenge"/>
 <result pre="challenge studyThe Lancet Infectious Diseases204202043544431978354 27van RietE.AinaiA.SuzukiT.HasegawaH.Mucosal IgA responses in" exact="influenza" post="virus infections; thoughts for vaccine designVaccine304020125893590022835738 28HuK.-F.Lövgren-BengtssonK.MoreinB.Immunostimulating complexes (ISCOMs)"/>
 <result pre="Xing Bing Xue Za Zhi 2020;41(2):145–51. Chinese. 31SharmaP.KumarA.Metabolic dysfunction associated" exact="fatty liver disease" post="increases risk of severe Covid-19Diabetes &amp;amp; Metabolic Syndrome: Clinical"/>
 <result pre="Bing Xue Za Zhi 2020;41(2):145–51. Chinese. 31SharmaP.KumarA.Metabolic dysfunction associated fatty" exact="liver disease" post="increases risk of severe Covid-19Diabetes &amp;amp; Metabolic Syndrome: Clinical"/>
 <result pre="the COVID-19 pandemicHeart1061720201296130132444504 34EdelmanR.DemingM.E.ToapantaF.R.HeuserM.D.ChrisleyL.BarnesR.S.WassermanS.S.BlackwelderW.C.HandwergerB.S.PasettiM.SiddiquiK.M.SzteinM.B.The SENIEUR protocol and the efficacy of" exact="hepatitis" post="B vaccination in healthy elderly persons by age, gender,"/>
 <result pre="Yan B. Yang X. Yang Effectiveness, immunogenicity, and safety of" exact="influenza" post="vaccines with MF59 adjuvant in healthy people of different"/>
</results>
